Cited by 924Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions

The DOI matches its Crossref record; 982 of the 982 references it cites were found in a registry or an index.

Drug-induced liver injury

Open access

Andrade, Raul J., Chalasani, Naga, Björnsson, Einar S., Suzuki, Ayako, Kullak-Ublick, Gerd A., Watkins, Paul B., Devarbhavi, Harshad, Merz, Michael, Lucena, M. Isabel, Kaplowitz, Neil, Aithal, Guruprasad P.·2019·Nature Reviews Disease Primers

DOI 10.1038/s41572-019-0105-0

Open this paper in CoChat — free account Open PDF

Abstract

Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as an unpredictable event with many drugs in common use. Drugs can be harmful to the liver in susceptible individuals owing to genetic and environmental risk factors. These risk factors modify hepatic metabolism and excretion of the DILI-causative agent leading to cellular stress, cell death, activation of an adaptive immune response and a failure to adapt, with progression to overt liver injury. Idiosyncratic DILI is a relative rare hepatic disorder but can be severe and, in some cases, fatal, presenting with a variety of phenotypes, which mimic other hepatic diseases. The diagnosis of DILI relies on the exclusion of other aetiologies of liver disease as specific biomarkers are still lacking. Clinical scales such as CIOMS/RUCAM can support the diagnostic process but need refinement. A number of clinical variables, validated in prospective cohorts, can be used to predict a more severe DILI outcome. Although no pharmacological therapy has been adequately tested in randomized clinical trials, corticosteroids can be useful, particularly in the emergent form of DILI related to immune-checkpoint inhibitors in patients with cancer.

Integrity signals

Registry

Crossref · 10.1038/s41572-019-0105-0

Cites

982 of 982 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

2 of 2

2 retracted

Items 601–800 of 982

Bosentan for the Treatment of Pulmonary Arterial Hypertension
Kenyon, K. W., & Nappi, J. M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c256 · Cited by 63
Hepatotoxicity of antifungal agents.
Song, J., & Deresinski, S. C. (2005) · PubMed · Cited by 63
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study
Paterson, J. M., Mamdani, M. M., Manno, M., & Juurlink, D. N. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111823 · Cited by 62
Sudden Death in Arthritic Children Receiving Large Doses of Indomethacin
Jacobs, J. C. (1967) · JAMA · doi:10.1001/jama.1967.03120120120029 · Cited by 62
Safety of Fenofibrate – US and Worldwide Experience
Roberts, W. C. (2008) · Cardiology · doi:10.1159/000174488 · Cited by 62
Ramipril-Associated Hepatotoxicity
Yeung, E., Wong, F. S.-H., Wanless, I. R., Shiota, K., Guindi, M. M., Joshi, S., & Gardiner, G. W. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-1493-rh · Cited by 62
Lamotrigine-induced rash in children
Dooley, J. M., Camfield, P. R., Gordon, K., Camfield, C. S., Wirrell, Z., & Smith, E. (1996) · Neurology · doi:10.1212/wnl.46.1.240 · Cited by 62
Hepatotoxicity of nucleoside reverse transcriptase inhibitors
(2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39947 · Cited by 62
Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia.
Rivkin, M., Simerzin, A., Zorde-Khvalevsky, E., Chai, C., Yuval, J., Rosenberg, N., Harari-Steinfeld, R., Schneider, R., Amir, G., Condiotti, R., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.031 · Cited by 62
Progressive bile duct injury after thiabendazole administration
Manivel, J. C., Bloomer, J. R., & Snover, D. C. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91009-2 · Cited by 61
Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury
Kim, S., & Naisbitt, D. J. (2015) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2016.8.1.3 · Cited by 61
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity
Keane, N. M., Pavlos, R. K., McKinnon, E., Lucas, A., Rive, C. M., Blyth, C. C., Dunn, D., Lucas, M., Mallal, S. A., & Phillips, E. J. (2014) · AIDS · doi:10.1097/qad.0000000000000345 · Cited by 61
Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s
Wen, B., Ma, L., & Zhu, M. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.02.001 · Cited by 61
Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology Group
Langholz, B. M., Skolnik, J. M., Barrett, J. S., Renbarger, J. L., Seibel, N. L., Zajicek, A., & Arndt, C. A. S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22882 · Cited by 61
SENSITISATION TO HALOTHANE-ALTERED LIVER COMPONENTS IN SEVERE HEPATIC NECROSIS AFTER HALOTHANE ANqSTHESIA
Mieli‐Vergani, G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92585-0 · Cited by 60
A Comparison between Two Strategies for Monitoring Hepatic Function during Antituberculous Therapy
Singanayagam, A., Sridhar, S., Dhariwal, J., Abdelaziz, D., Munro, K., Connell, D. W., George, P. M., Molyneaux, P. L., Cooke, G., Burroughs, A. K., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0850oc · Cited by 60
CONVERSION OF THE HIV PROTEASE INHIBITOR NELFINAVIR TO A BIOACTIVE METABOLITE BY HUMAN LIVER CYP2C19
Hirani, V., Raucy, J. L., & Lasker, J. M. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001743 · Cited by 60
Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
Faggioli, P. M., Paschale, M. D., Tocci, A., Luoni, M., Fava, S., Paoli, A. D., Tosi, A., & Cassi, E. (1997) · PubMed · Cited by 60
The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation
Watkins, P. B. (2019) · Clinical and Translational Science · doi:10.1111/cts.12629 · Cited by 60
Self-citation
Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database
Hunt, C. M., Yuen, N., Stirnadel-Farrant, H. A., & Suzuki, A. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.09.007 · Cited by 59
Self-citation
Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in Japan
Aiso, M., Takikawa, H., Tsuji, K., Kagawa, T., Watanabe, M., Tanaka, A., Sato, K., Sakisaka, S., Hiasa, Y., Takei, Y., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13288 · Cited by 59
CASE REPORT: Azithromycin-Induced Intrahepatic Cholestasis
Chandrupatla, S., Demetris, A. J., & Rabinovitz, M. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020170807742 · Cited by 58
Long‐term follow‐up of patients with mild to moderate drug‐induced liver injury
Bjornsson, E. S., Kalaitzakis, E., KLINTEBERG, V. A., ALEM, N., & Olsson, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03355.x · Cited by 58
Acetaminophen hepatotoxicity: Correspondence of selective protein arylation in human and mouse liver in vitro, in culture, and in vivo
Birge, R. B., Bartolone, J. B., HART, S. G. E., Nishanian, E. V., Tyson, C. A., Khairallah, E. A., & Cohen, S. D. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90150-s · Cited by 58
Intrahepatic Cholestasis and Phospholipidosis Associated With the Use of Trimethoprim–Sulfamethoxazole
Muñoz, S. J., Martinez-Hernandez, A., & Maddrey, W. C. (1990) · Hepatology · doi:10.1002/hep.1840120223 · Cited by 58
Trazodone-Induced Hepatotoxicity: A Case Report With Comments on Drug-Induced Hepatotoxicity
Fernandes, N. F., Martin, R. R., & Schenker, S. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Cited by 58
Veno-Occlusive Hepatic Disease of the Liver in Renal Transplantation: Is Azathioprine the Cause?
Liaño, F., Moreno, A., Matesanz, R., Teruel, J. L., Redondo, C., García-Martín, F., Orte, L., & Ortuño, J. Á. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185385 · Cited by 58
Fatal hepatic necrosis following imatinib mesylate therapy
Lin, N., Sarantopoulos, S., Stone, J. R., Galinsky, I. A., Stone, R. M., DeAngelo, D. J., & Soiffer, R. J. (2003) · Blood · doi:10.1182/blood-2003-07-2323 · Cited by 58
Human leukocyte antigen genetic risk factors of drug-induced liver toxicology
Grove, J. I., & Aithal, G. P. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.992414 · Cited by 58
Self-citation
Minocycline-induced liver injury.
Malcolm, A., Heap, T. R., Eckstein, R. P., & Lunzer, M. (1996) · PubMed · Cited by 57
The changing epidemiology of liver disease in HIV patients.
Soriano, V., Barreiro, P., & Sherman, K. E. (2013) · PubMed · Cited by 57
Chemotherapeutic agents and hepatotoxicity.
Perry, M. C. (1992) · PubMed · Cited by 57
Metformin-Induced Cholestatic Hepatitis
Nammour, F., Fayad, N. F., & Peikin, S. R. (2003) · Endocrine Practice · doi:10.4158/ep.9.4.307 · Cited by 57
Potential hepatotoxicity of lamotrigine
Fayad, M. N., Choueiri, R., & Mikati, M. A. (2000) · Pediatric Neurology · doi:10.1016/s0887-8994(99)00106-x · Cited by 57
Liver Reactions to Oral Low-Dose Tetracyclines
Bjornsson, E. S., Lindberg, J., & Olsson, R. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709007690 · Cited by 57
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
Tonyalı, Ö., Çoşkun, U., Yıldız, R., Karakan, T., Demırcı, U., Akyürek, N., Beneklı, M., & Buyukberber, S. (2009) · Medical Oncology · doi:10.1007/s12032-009-9284-y · Cited by 57
Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase
Holland, W. L., Morrison, T. E., Chang, Y., Wiernsperger, N., & Stith, B. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.016 · Cited by 57
Cyclophosphamide Hepatotoxicity in a Patient with Systemic Lupus Erythematosus
Bacon, A. M., & ROSENBERG, S. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-62 · Cited by 56
Topiramate and fulminant liver failure
Bjøm, K., Gjerstad, L., Bentdal, Ø. H., Osnes, S., & Schrumpf, E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79759-2 · Cited by 56
The Syndrome of Methoxyflurane-Associated Hepatitis
Joshi, P. H., & CONN, H. O. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-395 · Cited by 56
Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance
Russo, M. W., Steuerwald, N., Norton, H. J., Anderson, W. E., Foureau, D., Chalasani, N., Fontana, R. J., Watkins, P. B., Serrano, J., & Bonkovsky, H. L. (2016) · Liver International · doi:10.1111/liv.13312 · Cited by 56
Self-citation
Organic Anion Transporter oatp2-Mediated Interaction between Digoxin and Amiodarone in the Rat Liver
Kodawara, T., Masuda, S., 若杉, 博., Uwai, Y., Futami, T., Saito, H., Abe, T., & Inui, K. (2002) · Pharmaceutical Research · doi:10.1023/a:1016184211491 · Cited by 55
Fulminant hepatitis after lisinopril administration
Larrey, D. G., Babany, G., Bernuau, J., Andrieux, J., Degott, C., Pessayre, D., & Benhamou, J. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90496-n · Cited by 55
Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat
Tuncer, İ., Özbek, H., Ugras, S. N., & Bayram, İ. (2003) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00309 · Cited by 55
Reversible Control by Vitamin D of Granulocytes and Bacteria in the Lungs of Mice: An Ovalbumin-Induced Model of Allergic Airway Disease
Gorman, S., Weeden, C. E., Tan, D. H. W., Scott, N. M., Hart, J., Foong, R. E., Mok, D., Stephens, N., Zosky, G. R., & Hart, P. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067823 · Cited by 55
Intravenous acetylcysteine for the treatment of acetaminophen overdose
Klein‐Schwartz, W., & Doyon, S. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.537261 · Cited by 55
A Fatal Case of Fulminant Hepatic Necrosis Following Sevoflurane Anesthesia
Turillazzi, E., D’Errico, S., Neri, M., Riezzo, I., & Fineschi, V. (2007) · Toxicologic Pathology · doi:10.1080/01926230701584148 · Cited by 55
Cytosine arabinoside in acute granulocytic leukemia
Goodell, B. W., Leventhal, B. G., & Henderson, E. S. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971124599 · Cited by 55
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement
Schwarz, R. E., Berlin, J. D., Lenz, H. J., Nordlinger, B., Rubbia‐Brandt, L., & Choti, M. A. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00558.x · Cited by 54
The mechanism of cyclosporine toxicity induced by clarithromycin
Spicer, S. T., Liddle, C., Chapman, J. R., Barclay, P. L., Nankivell, B. J., Thomas, P., & O'Connell, P. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.54310.x · Cited by 54
The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis
Bensimon, G., & Doble, A. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.6.525 · Cited by 54
Hepatotoxicity of ketoconazole in Sprague-Dawley rats: glutathione depletion, flavin-containing monooxygenases-mediated bioactivation and hepatic covalent binding
Rodriguez, R. J., & Buckholz, C. J. (2003) · Xenobiotica · doi:10.1080/0049825031000072243 · Cited by 54
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
Tam, C. M., Chan, S. L., Kam, K. M., Goodall, R. L., & Mitchison, D. A. (2002) · PubMed · Cited by 54
Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure
Schimanski, C. C., Burg, J., Möhler, M., Höhler, T., Kanzler, S., Otto, G., Galle, P. R., & Lohse, A. W. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.010 · Cited by 53
Antiretroviral-associated liver injury
Ogedegbe, A., & Sulkowski, M. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00023-0 · Cited by 53
Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis
Tremlett, H. L., & Oger, J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0619-5 · Cited by 53
Efficacy and Safety of Coadministration of Ezetimibe and Statins in Elderly Patients with Primary Hypercholesterolaemia
Lipka, L., Sager, P. T., Strony, J. T., Yang, B., Suresh, R., & Veltri, E. P. (2004) · Drugs & Aging · doi:10.2165/00002512-200421150-00005 · Cited by 53
The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: A case control study
Cotte, L., Bénet, T., Billioud, C., Miailhes, P., Scoazec, J., Ferry, T., Brochier, C., Boibieux, A., Vanhems, P., Chevallier, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.030 · Cited by 53
Endothelin-receptor antagonist treatment of portopulmonary hypertension
Hinterhuber, L., Graziadei, I., Kähler, C. M., Jaschke, W. R., & Vogel, W. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00466-5 · Cited by 53
Rechallenge in drug-induced liver injury: the attractive hazard
Andrade, R. J., Robles, M., & Lucena, M. I. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903397378 · Cited by 52
Self-citation
Restoration of Bile Ducts in Drug-induced Vanishing Bile Duct Syndrome Due to Zonisamide
Vuppalanchi, R., Chalasani, N., & Saxena, R. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213342.78475.48 · Cited by 52
Self-citation
Acute Hepatitis After Tetrahydroaminoacridine Administration for Alzheimerʼs Disease
Hammel, P. R., Larrey, D. G., Bernuau, J., Kalafat, M., Fréneaux, E., Babany, G., Degott, C., Feldmann, G., Pessayre, D., & Benhamou, J. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199006000-00021 · Cited by 52
Fulminant Hepatitis and Fatal Toxic Epidermal Necrolysis (Lyell Disease) Coincident With Clarithromycin Administration in an Alcoholic Patient Receiving Disulfiram Therapy
Masiá, M., Gutiérrez, F., Jimeno, A., Navarro‐Ruiz, A., Borrás, J., Matarredona, J., & Martín-Hidalgo, A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.4.474 · Cited by 52
Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury
Benesic, A., Rotter, I., Dragoi, D., Weber, S., Buchholtz, M.-L., & Gerbes, A. L. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.049 · Cited by 52
In vivo effect of clarithromycin on multiple cytochrome P450s.
BRUCE, M., Hall, S. D., HAEHNERDANIELS, B., & Gorski, J. C. (2001) · PubMed · Cited by 51
Progressive Cholestatic Liver Disease Associated with Clarithromycin Treatment
Fox, J. C., Szyjkowski, R. D., Sanderson, S. O., & Levine, R. A. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00970002042006011 · Cited by 51
Hepatotoxicity following vincristine therapy
Saghir, N. S. E., & Hawkins, K. A. (1984) · Cancer · doi:10.1002/1097-0142(19841101)54:9 · Cited by 51
Losartan-Induced Hepatic Injury
Tabak, F., Mert, A., Özaras, R., Biyikli, M., Ozturk, R., Özbay, G., Şentürk, H., & Aktuğlu, Y. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200205000-00022 · Cited by 51
Avoiding idiosyncratic DILI: Two is better than one
Kaplowitz, N. (2013) · Hepatology · doi:10.1002/hep.26295 · Cited by 51
Self-citation
Effect of Valproate Dose on Formation of Hepatotoxic Metabolites
Anderson, G. D., Acheampong, A., Wilensky, A. J., & Levy, R. H. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb02355.x · Cited by 51
Adverse Reactions to Trimethoprim/Sulfamethoxazole in AIDS
Floris-Moore, M., Amodio-Groton, M. I., & Catalano, M. T. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d179 · Cited by 51
A Systematic Review of Catechol-O-Methyltransferase Inhibitors
Marsala, S. Z., Gioulis, M., Ceravolo, R., & Tinazzi, M. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31825c034a · Cited by 51
Nitrofurantoin-induced chronic active hepatitis.
Amit, G., Cohen, P., & Ackerman, Z. (2002) · PubMed · Cited by 50
Ketamine Abuse, Biliary Tract Disease, and Secondary Sclerosing Cholangitis
Turkish, A. R., Luo, J. J., & Lefkowitch, J. H. (2013) · Hepatology · doi:10.1002/hep.26459 · Cited by 50
Liver Damage Induced by Coumarin Anticoagulants
Ehrenforth, S., Schenk, J. F., & Scharrer, I. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996428 · Cited by 50
Higher Occurrence of Hepatotoxicity and Rash in Patients Treated with Oxacillin, Compared with Those Treated with Nafcillin and Other Commonly Used Antimicrobials
Maraqa, N., Gomez, M. M., Rathore, M. H., & Alvarez, A. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338047 · Cited by 50
Reye's syndrome: Mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate
Martens, M. E., Chang, C.-H., & Lee, C. P. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90646-6 · Cited by 50
Innate immunity and acetaminophen-induced liver injury: Why so many controversies?
Jaeschke, H. (2008) · Hepatology · doi:10.1002/hep.22556 · Cited by 50
Ticlopidine-Induced Cholestatic Hepatitis
Skurnik, Y. D., Tcherniak, A., Edlan, K., & Sthoeger, Z. M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1a406 · Cited by 50
Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view
Schmidt, D., Arroyo, S., Baulac, M., Dam, M., Dulac, O., Friis, M. L., Kälviäinen, R. K., Krämer, G., Parys, J. A. P. V., Pedersen, B., et al. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00870.x · Cited by 50
Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro.
Kapetanović, I. M., Torchin, C. D., Thompson, C. D., Miller, T. A., McNeilly, P. J., Macdonald, T. L., Kupferberg, H. J., Perhach, J. L., Sofia, R. D., & Strong, J. M. (1998) · PubMed · Cited by 49
Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug‐Induced Liver Injury Network ( DILIN )
Hayashi, P. H., Barnhart, H. X., Fontana, R. J., Chalasani, N., Davern, T. J., Talwalkar, J. A., Reddy, K. R., Stolz, A., Hoofnagle, J. H., & Rockey, D. C. (2014) · Liver International · doi:10.1111/liv.12540 · Cited by 49
Self-citation
Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity
Andrade, R. J., Lucena, M. I., Fernández, M. C., Vega, J. L., García‐Cortés, M., Casado, M., Guerrero-Sanchez, E., & Pulido-Fernández, F. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200208000-00014 · Cited by 49
Self-citation
Biochemical Changes and Morphological Alterations of the Liver in Guinea‐Pigs after Administration of Simvastatin (HMG CoA Reductase‐Inhibitor)
Horsmans, Y., Desager, J. P., & Harvengt, C. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00840.x · Cited by 49
In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations
Li, Y., Slatter, J. G., Zhang, Z., Li, Y., Doss, G. A., Braun, M. P., Stearns, R. A., Dean, D. C., Baillie, T. A., & Tang, W. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019018 · Cited by 49
Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.
Klein, S. M., & Khan, M. A. (1983) · PubMed · Cited by 48
Venoocclusive Liver Disease (VOD) as a Complication of Wilms' Tumour Management in the Series of Consecutive 206 Patients
Czauderna, P. S., Katski, K., Kowalczyk, J., Kurylak, A., Łopatka, B., Skotnicka-Klonowicz, G., Sawicz-Birkowska, K., & Godzinski, J. K. (2000) · European Journal of Pediatric Surgery · doi:10.1055/s-2008-1072380 · Cited by 48
Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury
Suzuki, A., Yuen, N., Walsh, J. S. A., Papay, J. I., Hunt, C. M., & Diehl, A. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.03.034 · Cited by 48
Self-citation
Sex Bias in Experimental Immune-Mediated, Drug-Induced Liver Injury in BALB/c Mice: Suggested Roles for Tregs, Estrogen, and IL-6
Cho, J., Kim, L., Li, Z., Rose, N. R., Talor, M. V., & Njoku, D. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061186 · Cited by 48
Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy
Greinacher, A. (2004) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2.3.339 · Cited by 48
Hepatic Safety of Itraconazole
Gupta, A. K., Chwetzoff, E., Rosso, J. Q. D., & Baran, R. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540200600302 · Cited by 48
Hypersensitivity Syndrome Induced by Anticonvulsants: Possible Cross‐Reactivity Between Carbamazepine and Lamotrigine
Aouam, K., Romdhane, F. B., Loussaïef, C., Salem, R., Toumi, A., Belhadjali, H., Chaabane, A., Boughattas, N. A., & Chakroun, M. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009344985 · Cited by 48
Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients
Ena, J., Amador, C., Benito, C., Fenoll, V., & Pasquau, F. (2003) · International Journal of STD & AIDS · doi:10.1258/09564620360719840 · Cited by 48
Fatal Hepatic Necrosis Due to Pyrimethamine-Sulfadoxine (Fansidar)
Zitelli, B. J., ALEXANDER, J., TAYLOR, S., MILLER, K. D., HOWRIE, D. L., KURITSKY, J. N., PEREZ, T. H., & Thiel, D. H. V. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-393 · Cited by 48
Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury
George, N. E., Chen, M., Yuen, N., Hunt, C. M., & Suzuki, A. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.01.018 · Cited by 48
Self-citation
Zonisamide ? a review of experience and use in partial seizures
Wilfong, A. A., & Willmore, L. J. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.3.269 · Cited by 47
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
Andersson, B., Gajewski, J., Donato, M. L., Giralt, S., Gian, V. G., Wingard, J. R., Tarantolo, S., Fernandez, H. F., Hu, W. W., Blume, K. G., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702351 · Cited by 47
6-Thioguanine as a cause of toxic veno-occlusive disease of the liver
Satti, M., Weinbren, K., & Gordon‐Smith, E. C. (1982) · Journal of Clinical Pathology · doi:10.1136/jcp.35.10.1086 · Cited by 47
Safety profile of piperacillin/tazobactam in phase I and III clinical studies
Kuye, O., Teal, J. J., Vries, V. G. D., Morrow, C. A., & Tally, F. P. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.suppl_a.113 · Cited by 47
Quinidine Hypersensitivity and Liver Involvement
Geltner, D., Chajek, T., Rubinger, D., & Levij, I. S. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80248-x · Cited by 47
Drug-Induced Liver Injury Due to Antimicrobials, Central Nervous System Agents, and Nonsteroidal Anti-Inflammatory Drugs
Devarbhavi, H. C., & Andrade, R. J. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1375956 · Cited by 46
Self-citation
Fatal liver failure with atorvastatin
Perger, L., Kohler, M., Fattinger, K. E., Flury, R., Meier, P. J., & Pauli‐Magnus, C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00464-1 · Cited by 46
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug‐induced liver injury
Ulzurrun, E., Stephens, C. M., Crespo, E., Ruiz‐Cabello, F., Ruiz‐Nuñez, J., Sáenz-López, P., Moreno‐Herrera, I., Robles‐Díaz, M., Hallal, H., Planas, J. M. M., et al. (2013) · Liver International · doi:10.1111/liv.12193 · Cited by 46
Self-citation
Mechanism-Based Inactivation of Cytochrome P450s 1A2 and 3A4 by Dihydralazine in Human Liver Microsomes
Masubuchi, Y., & Horie, T. (1999) · Chemical Research in Toxicology · doi:10.1021/tx9901276 · Cited by 46
Mechanism of Exacerbative Effect of Progesterone on Drug-Induced Liver Injury
Toyoda, Y., Endo, S., Tsuneyama, K., Miyashita, T., Yano, A., Fukami, T., Nakajima, M., & Yokoi, T. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr326 · Cited by 46
Reversible cholestasis with bile duct injury following azathioprine therapy. A case report
Horsmans, Y., Rahier, J., & Geubel, A. P. (1991) · Liver International · doi:10.1111/j.1600-0676.1991.tb00497.x · Cited by 46
Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors
Khurana, V., Minocha, M., Pal, D., & Mitra, A. K. (2014) · Drug metabolism and drug interactions · doi:10.1515/dmdi-2014-0014 · Cited by 46
FK506 hepatotoxicity in liver allograft recipients.
Fisher, A., Mor, E., Hytiroglou, P., Emre, S., Boccagni, P., Chodoff, L., Sheiner, P. A., Schwartz, M., Thung, S. N., & Miller, C. M. (1995) · PubMed · Cited by 45
Intestinal and liver toxicity of antineoplastic drugs.
McDonald, G. B., & Tirumali, N. (1984) · PubMed Central · Cited by 45
Glyburide-Induced Hepatitis
GOODMAN, R. C., DEAN, P. J., RADPARVAR, A., & KITABCHI, A. E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-837 · Cited by 45
Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro
Kapetanović, I. M., Torchin, C. D., Strong, J. M., Yonekawa, W. D., Lu, C., Li, A. P., Dieckhaus, C. M., Santos, W. L., Macdonald, T. L., Sofia, R. D., et al. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00058-3 · Cited by 45
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
Cantoni, N., Gerull, S., Heim, D. A., Halter, J. P., Bucher, C. M., Buser, A. S., Tsakiris, D. Α., Passweg, J. R., Tichelli, A., Stern, M., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.137 · Cited by 45
Azathioprine in psoriasis.
Greaves, M. W., & Dawber, R. P. R. (1970) · BMJ · doi:10.1136/bmj.2.5703.237-b · Cited by 45
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
Tran, A., Housset, C., Boboc, B., Tourani, J. M., Carnot, F., & Berthelot, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90905-q · Cited by 45
End‐stage methotrexate‐related liver disease is rare and associated with features of the metabolic syndrome
Dawwas, M. F., & Aithal, G. P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12912 · Cited by 45
Self-citation
Low dose amiodarone causing pseudo-alcoholic cirrhosis
Singhal, A. (2003) · Age and Ageing · doi:10.1093/ageing/32.2.224 · Cited by 45
Internet Accounts of Serious Adverse Drug Reactions
Butt, T. F., Cox, A. R., Oyebode, J. R., & Ferner, R. E. (2012) · Drug Safety · doi:10.1007/bf03262001 · Cited by 44
LEVETIRACETAM AS A POSSIBLE CAUSE OF FULMINANT LIVER FAILURE
Tan, T. C. H., de Boer, B., Mitchell, A., Delrivière, L., Adams, L. A., Jeffrey, G. P., & MacQuillan, G. C. (2008) · Neurology · doi:10.1212/01.wnl.0000324604.11657.c6 · Cited by 44
N-Acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus
Kaufmann, G. R., Wenk, M., Taeschner, W., Peterli, B., Gyr, K. E., Meyer, U., & Haefeli, W. E. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90168-x · Cited by 44
Idiopathic portal hypertension associated with cytotoxic drugs.
Shepherd, P. C. A., & Harrison, D. J. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.3.206 · Cited by 44
Hepatotoxicity in the treatment of acute lymphoblastic leukaemia
Topley, J. M., Benson, J., Squier, M. V., & Chessells, J. M. (1979) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950070415 · Cited by 44
Voriconazole hepatotoxicity in severe liver dysfunction
Solís‐Muñoz, P., López, J. C., Bernal, W. E., Willars, C., Verma, A., Heneghan, M. A., Wendon, J. A., & Auzinger, G. M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.011 · Cited by 44
A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome
Sonderup, M. W., Wainwright, H., Hall, P. D. L. Μ., Hairwadzi, H., & Spearman, C. W. (2015) · Hepatology · doi:10.1002/hep.27710 · Cited by 43
Cholestatic liver injury after glimepiride therapy
Chounta, A., Zouridakis, S., Ellinas, C., Tsiodras, S., Zoumpouli, C., Kopanakis, S., & Giamarellou, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.011 · Cited by 43
Fatal hepatic vascular toxicity of DTIC.Is it really a rare event?
Ceci, G., Bella, M., Melissari, M., Gabrielli, M., Bocchi, P., & Cocconi, G. (1988) · Cancer · doi:10.1002/1097-0142(19880515)61:10 · Cited by 43
Metoprolol-lnduced Hepatitis: Rechallenge and Drug Oxidation Phenotyping
Larrey, D. G., HENRION, J., HELLER, F., BABANY, G., Degott, C., Pessayre, D., & BENHAMOU, J.-P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-67 · Cited by 43
Retrospective Study of Hepatic Enzyme Elevations in Children Treated With Olanzapine, Divalproex, and Their Combination
Gonzalez–Heydrich, J., Raches, D., Wilens, T. E., Leichtner, A. M., & Mezzacappa, E. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200310000-00014 · Cited by 43
Thrombolytic action of ticlopidine: possible mechanisms
Gryglewski, R. J., Korbut, R., Świȩs, J., Kostka-Trabka, E., Bieroń, K., & Robak, J. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00256-7 · Cited by 43
Pregabalin-Induced Hepatotoxicity
Sendra, J., Junyent, T. T., & Pellicer, M. J. R. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q032 · Cited by 43
Intrahepatic Cholestasis after Griseofulvin Administration
Chiprut, R. O., Viteri, A. L., Jamroz, C., & Dyck, W. P. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80327-7 · Cited by 43
Nonsteroidal anti-inflammatory drugs. Proposed guidelines for monitoring toxicity.
Bush, T. M., Shlotzhauer, T. L., & Imai, K. (1991) · PubMed Central · Cited by 43
Hepatic injury during doxorubicin therapy.
Avilés, A., Herrera, J., Ramos, E., Ambríz, R., Aguirre, J. P. V., & Pizzuto, J. (1984) · PubMed · Cited by 43
Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH
Flentje, M., Weirich, A., Pötter, R., & Ludwig, R. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90427-8 · Cited by 42
Drug-induced liver injury: a safety review
García‐Cortés, M., Ortega‐Alonso, A., Lucena, M. I., & Andrade, R. J. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1505861 · Cited by 42
Self-citation
Oxcarbazépine et syndrome DRESS : un cas pédiatrique révélé par une hépatite fulminante
Bosdure, E., Caño, A., Roquelaure, B., Reynaud, R., Boyer, M. G., Viard, L., & Sarles, J. (2004) · Archives de Pédiatrie · doi:10.1016/j.arcped.2004.05.018 · Cited by 41
Itraconazole and Fluconazole and Certain Rare, Serious Adverse Events
Bradbury, B. D., & Jick, S. S. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.697.34072 · Cited by 41
HEPATOTOXICITY RELATED TO ITRACONAZOLE : REPORT OF THREE CASES
Adriaenssens, B., Roskams, T., Steger, P. H., & Steenbergen, W. V. (2001) · Acta Clinica Belgica · doi:10.1179/acb.2001.055 · Cited by 41
The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study
Chen, R., Zhang, Y., Tang, S., Lv, X., Wu, S., Sun, F., Xia, Y., & Zhan, S. Y. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12211 · Cited by 41
Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non‐cirrhotic portal hypertension. RESULTS FROM MRC CML II TRIAL COMPARING BUSULPHAN WITH BUSULPHAN AND THIOGUANINE
Shepherd, P. C. A., Fooks, J., Gray, R. G., & Allan, N. C. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb04520.x · Cited by 41
Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury
Weaver, R. J., Betts, C. J., Blomme, E. A. G., Gerets, H. H. J., Jensen, K. G., Hewitt, P. G., Juhila, S., Labbe, G., Liguori, M. J., Mesens, N., et al. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1341489 · Cited by 41
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
Kowalec, K., Wright, G. E. B., Drögemöller, B. I., Aminkeng, F., Bhavsar, A. P., Kingwell, E., Yoshida, E. M., Traboulsee, A. L., Marrie, R. A., Kremenchutzky, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0168-y · Cited by 41
Self-citation
Clozapine-Induced Fatal Fulminant Hepatic Failure: A Case Report
Chang, A., Krygier, D. S., Chatur, N., & Yoshida, E. M. (2009) · Canadian Journal of Gastroenterology · doi:10.1155/2009/503916 · Cited by 40
Voriconazole for serious fungal infections
Gothard, P., & Rogers, T. R. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.0099.x · Cited by 40
Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia
Kong, J. H., Yoo, S.-H., Lee, K. E., Nam, S. H., Kwon, J. M., Lee, S. M., Chang, H. J., Choi, M. Y., Cho, M. S., Mun, Y., et al. (2007) · Acta Haematologica · doi:10.1159/000111092 · Cited by 40
Uncommon Side Effect of MMF in Renal Transplant Recipients
Balal, M., Demir, E., Paydaş, S., Sertdemır, Y., & Erken, U. (2005) · Renal Failure · doi:10.1080/08860220500200171 · Cited by 40
Hepatotoxicity with encephalopathy associated with aspirin therapy in rheumatoid arthritis
Ulshen, M. H., Grand, R. J., Crain, J. D., & Gelfand, E. W. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)81252-9 · Cited by 40
Acute Hepatic Failure in a Child Treated With Lamotrigine
Arnon, R., Vivo, D. C. D., DeFelice, A. R., & Kazlow, P. G. (1998) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00196-3 · Cited by 40
Granulomatous hepatitis associated with glyburide
Saw, D., Pitman, E. R., Maung, M., Savasatit, P., Wasserman, D. M., & Yeung, C. K. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093822 · Cited by 40
Oxidation of Plasma Cysteine/Cystine and GSH/GSSG Redox Potentials by Acetaminophen and Sulfur Amino Acid Insufficiency in Humans
Mannery, Y. O., Ziegler, T. R., Park, Y. H., & Jones, D. P. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166421 · Cited by 40
Pulmonary and Hepatic Toxicity Due to Nitrofurantoin and Fluconazole Treatment
Linnebur, S. A., & Parnes, B. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d306 · Cited by 40
DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity
Shimizu, Y., Dobashi, K., Mita, Y., Endou, K., Moriya, S., Osano, K., Koike, Y., Higuchi, S., YABE, S., Utsugi, M., et al. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.09.002 · Cited by 40
Hepatic Damage by Natural Remedies
Medina-Caliz, I., Gonzalez-Jimenez, A., Garcia-Cortes, M., Lucena, M. I., & Andrade, R. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1623518 · Cited by 40
Self-citation
Methotrexate-induced liver abnormalities in rheumatoid arthritis.
Bridges, S. L., Alarcón, G. S., & Koopman, W. J. (1989) · PubMed · Cited by 39
Sulindac (Clinoril) hepatitis
Dhand, A. K., LaBrecque, D. R., & Metzger, J. A. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90023-8 · Cited by 39
Drug-induced hepatitis: a rare complication of oral anticoagulants
Höhler, T., Schnütgen, M., Helmreich-Becker, I., Mayet, W. J., & Büschenfelde, K. H. M. Z. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80326-5 · Cited by 39
Ceftriaxone-induced toxic hepatitis
Peker, E., Çağan, E., & Dogan, M. S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2669 · Cited by 39
Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?
Roth, R. A., Maiuri, A. R., & Ganey, P. E. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237578 · Cited by 39
Fosinopril-induced prolonged cholestatic jaundice and pruritus: first case report
Nunes, A. C. R., Amaro, P., Maçôas, F., Cipriano, A., Martins, I., Rosa, A., Pimenta, I., Donato, A., & Freitas, D. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200103000-00011 · Cited by 38
Estradiol and progesterone modulate halothane-induced liver injury in mice
Toyoda, Y., Miyashita, T., Endo, S., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.03.031 · Cited by 38
Risperidone and liver function tests in children and adolescents: A short-term prospective study
Erdoğan, A., Atasoy, N., Akkurt, H., Ozturk, D., Karaahmet, E., Yaluğ, İ., Yaluğ, K., Ankaralı, H. Ç., & Balcıoğlu, İ. C. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.032 · Cited by 38
Hepatic Effects of Halothane, Isoflurane or Sevoflurane Anaesthesia in Dogs
Topal, A., Gül, N. Y., İlçöl, Y. Ö., & Görgül, O. S. (2003) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1111/j.1439-0442.2004.00589.x · Cited by 38
A Rare Case of Propofol-Induced Acute Liver Failure and Literature Review
Kneiseler, G., Bachmann, H. S., Bechmann, L. P., Dechêne, A., Heyer, T., Baba, H. A., Saner, F. H., Jochum, C., Gerken, G., & Canbay, A. E. (2010) · Case Reports in Gastroenterology · doi:10.1159/000262448 · Cited by 38
Use of population modeling to define rational monitoring of amiodarone hepatic effects*1
POLLAK, P. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.008 · Cited by 38
Appropriate Use of Nevirapinefor Long‐Term Therapy
Leith, J., Piliero, P. J., Storfer, S. P., Mayers, D. L., & Hinzmann, R. (2005) · The Journal of Infectious Diseases · doi:10.1086/431606 · Cited by 38
Mild Isoniazid-Induced Liver Injury in Humans Is Associated with an Increase in Th17 Cells and T Cells Producing IL-10
Metushi, I. G., Zhu, X., Chen, X., Gardam, M. A., & Uetrecht, J. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500013z · Cited by 38
When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)
Bessone, F., Hernández, N., Mendizábal, M., Sánchez, A., Paraná, R., Arrese, M. A., Tagle, M., Girala, M., Lizarzábal, M., Carrera, E., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.778 · Cited by 38
Self-citation
Telithromycin
Wellington, K., & Noble, S. (2004) · Drugs · doi:10.2165/00003495-200464150-00006 · Cited by 38
Veno-occlusive disease of the liver induced by low-dose cyclophosphamide.
Modzelewski, J. R., Daeschner, C. W., Joshi, V. V., Mullick, F., & Ishak, K. G. (1994) · PubMed · Cited by 37
Pergolide As Primary Therapy for Macroprolactinomas
Orrego, J. J., Chandler, W. F., & Barkan, A. L. (2000) · Pituitary · doi:10.1023/a:1012836331506 · Cited by 37
Outcome of acute liver failure in the elderly1
Schiφdt, F. V., Chung, R. T., Schilsky, M. L., Hay, J. E., Christensen, E., & Lee, W. M. (2009) · Liver Transplantation · doi:10.1002/lt.21865 · Cited by 37
Dihydralazine Hepatitis: Report of a Case and Review of the Literature
Pariente, A. E., Pessayre, D., Bernuau, J., Degott, C., & Benhamou, J. (2009) · Digestion · doi:10.1159/000198919 · Cited by 37
Methodology to Assess Clinical Liver Safety Data
Merz, M., Lee, K. R., Kullak-Ublick, G. A., Brueckner, A., & Watkins, P. B. (2014) · Drug Safety · doi:10.1007/s40264-014-0184-5 · Cited by 37
Self-citation
Desensitization to co-trimoxazole (trimethoprimsulphamethoxazole) in HIV-infected patients: Is patch testing a useful predictor of reaction?
Gompels, M. M., Simpson, N. B., Snow, M., Spickett, G., & Ong, E. L. C. (1999) · Journal of Infection · doi:10.1016/s0163-4453(99)90078-6 · Cited by 37
Successful orthotopic liver transplantation after trimethoprim–sulfamethoxazole associated fulminant liver failure
Zaman, F. A., Ye, G., Abreo, K. D., Latif, S., & Zibari, G. B. (2003) · Clinical Transplantation · doi:10.1034/j.1399-0012.2003.00040.x · Cited by 37
Possible Gatifloxacin-Induced Fulminant Hepatic Failure
Coleman, C. I., Spencer, J. V., Chung, J., & Reddy, P. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a414 · Cited by 37
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response
Whritenour, J., Ko, M., Zong, Q., Wang, J., Tartaro, K., Schneider, P., Olson, E., Van Volkenburg, M., Serrano, J., Hayashi, P., et al. (2017) · Journal of Immunotoxicology · doi:10.1080/1547691x.2016.1254305 · Cited by 37
Self-citation
Cholestatic Hepatic Injury Related to Warfarin Exposure
Adler, E. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360210235037 · Cited by 37
Subfulminant hepatitis requiring liver transplantation following ibuprofen overdose
Laurent, S., Rahier, J., Geubel, A. P., Lerut, J. P., & Horsmans, Y. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020001093.x · Cited by 36
Gliclazide-induced acute hepatitis
Dourakis, S. P., Tzemanakis, E. N., Sinani, C., Kafiri, G., & Hadziyannis, S. J. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012010-00021 · Cited by 36
Candesartan Cilexetil-Induced Severe Hepatotoxicity
Basile, G., Villari, D., Gangemi, S., Ferrara, T., Accetta, M. G., & Nicita-Mauro, V. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200303000-00017 · Cited by 36
Hepatic Dysfunction Due to Intravenous Abuse of Methylphenidate Hydrochloride
Mehta, H., Murray, B., & Loludice, T. A. (1984) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198404000-00010 · Cited by 36
Flucloxacillin-induced liver injury
Andrews, E., & Daly, A. K. (2008) · Toxicology · doi:10.1016/j.tox.2008.08.009 · Cited by 36
Captopril-Induced Jaundice: Report of 2 Cases and a Review of 13 Additional Reports in the Literature
Schattner, A., Kozak, N., & Friedman, J. A. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200110000-00016 · Cited by 36
L-TRYPTOPHAN AS AN ADJUNCT TO TREATMENT OF BULIMIA NERVOSA
Mira, M. W., & Abraham, S. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91534-1 · Cited by 36
Development and Characterization of a New Model of Tacrine-Induced Hepatotoxicity: Role of the Sympathetic Nervous System and Hypoxia-Reoxygenation
Stachlewitz, R. F., Arteel, G. E., Raleigh, J. A., Connor, H. D., Mason, R. P., & Thurman, R. G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36973-3 · Cited by 36
Topiramate increases the risk of valproic acid–induced encephalopathy
Noh, Y., Kim, D. W., Chu, K., Lee, S., Jung, K., Moon, H., & Lee, S. H. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03532.x · Cited by 35
Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients
Rangnekar, A. S., Meinzer, C., Durkalski, V., McGuire, B. M., Lee, W. M., & Fontana, R. J. (2013) · Liver Transplantation · doi:10.1002/lt.23688 · Cited by 35
Mitochondrial DNA Levels in Fat and Blood Cells from Patients with Lipodystrophy or Peripheral Neuropathy and the Effect of 90 Days of High-Dose Coenzyme Q Treatment: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Christensen, E. R., Stegger, M., Jensen‐Fangel, S., Laursen, A. L., & Østergaard, L. J. (2004) · Clinical Infectious Diseases · doi:10.1086/424881 · Cited by 35
Final Report of the National Halothane Study
Bunker, J. P. (1968) · Anesthesiology · doi:10.1097/00000542-196803000-00001 · Cited by 35
Chemotherapy-induced sclerosing cholangitis
Sandrasegaran, K., Alazmi, W. M., Tann, M. A., Fogel, E. L., McHenry, L., & Lehman, G. A. (2006) · Clinical Radiology · doi:10.1016/j.crad.2006.02.013 · Cited by 35
Micronodular cirrhosis after thiabendazole
Roy, M. A., Nugent, F. W., & Aretz, H. T. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01540282 · Cited by 35
Sirolimus-associated hepatotoxicity in the kidney graft recipient
Niemczyk, M., Wyzgał, J., Perkowska, A., Porowski, D., & Pączek, L. (2005) · Transplant International · doi:10.1111/j.1432-2277.2005.00210.x · Cited by 35
Hepatotoxicity Associated with Carvedilol
Hagmeyer, K. O., & Stein, J. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10239 · Cited by 35
Notes from the field: Acute Hepatitis and Liver Failure Following the Use of a Dietary Supplement Intended for Weight Loss or Muscle Building — May–October 2013
Park, S. Y., Viray, M. A., Johnston, D. W., Taylor, E., Chang, A. S., Martin, C. A., Schier, J. G., Lewis, L. S., Levri, K. M., & Chatham‐Stephens, K. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 35
Acetaminophen Dose Does Not Predict Outcome in Acetaminophen-Induced Acute Liver Failure
The Acute Liver Failure Study Group, Gregory, B., Larson, A. M., REISCH, J. S., & Lee, W. M. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181db8764 · Cited by 35
Glatiramer acetate for the treatment of multiple sclerosis
Wolinsky, J. S. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.4.875 · Cited by 34
Terbinafine-induced hepatic dysfunction
Chambers, W. M., Millar, A. W., Jain, S., & Burroughs, A. K. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200109000-00021 · Cited by 34
Acute hepatitis after riluzole administration
Remy, A., Camu, W., Ramos, J., Blanc, P., & Larrey, D. G. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80115-9 · Cited by 34
Natural Killer Cells Mediate Severe Liver Injury in a Murine Model of Halothane Hepatitis
Dugan, C. M., Fullerton, A. M., Roth, R. A., & Ganey, P. E. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr005 · Cited by 34
Fatal hepatitis with leflunomide and itraconazole
Legras, A., Bergemer-Fouquet, A.-M., & Jonville‐Béra, A. ‐. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01177-4 · Cited by 34

Research works printed but not linked: 3

Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001).
Sanjuan-Jimenez, R. et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract]. Hepatology 66, 423A (2017).
Abu-Sbeih, H., Styskel, B., Blechazz, B., Chalasani, N. & Miller, E. Clinically significant hepatotoxicity due to immune checkpoint inhibitors is rare but leads to treatment discontinuations in high proportion. Hepatology 68, 25A (2018).

Sorted by citations

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citation
Acute Pancreatitis: Diagnosis and Treatment
Szatmary, P., Grammatikopoulos, T., Cai, W., Huang, W., Mukherjee, R., Halloran, C. M., Beyer, G., & Sutton, R. (2022) · Drugs · doi:10.1007/s40265-022-01766-4 · Cited by 684
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Role of liver sinusoidal endothelial cells in liver diseases
Gracia‐Sancho, J., Caparrós, E., Fernández‐Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 436
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Self-citation

See all 924

Authors: Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., & Aithal, G. P.
Affiliations: Indiana University School of Medicine (US)
Duke University (US)
Novartis (Switzerland) (CH)
University of North Carolina at Chapel Hill (US)
St.John's Medical College Hospital (IN)
University of Zurich (CH)
Spanish Clinical Research Network (ES)
Nottingham University Hospitals NHS Trust (GB)
Corresponding author: Lucena, M. Isabel
ORCID: Chalasani, Naga
Suzuki, Ayako
Kullak-Ublick, Gerd A.
Watkins, Paul B.
Devarbhavi, Harshad
Merz, Michael
Lucena, M. Isabel
Kaplowitz, Neil
Aithal, Guruprasad P.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2019-08-22
Volume: 5
Issue: 1
Pages: 58-58
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-019-0105-0
OpenAlex: W1565605888
Cited by: 924
References: 982
Citations by year: 2026: 152 · 2025: 197 · 2024: 161 · 2023: 127 · 2022: 145 · 2021: 97 · 2020: 38
FWCI: 9.11
Type: journal article
Language: en
Open access: green
www.zora.uzh.ch
Licence: other-oa
www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords: drug-induced liver injury, idiosyncratic drug reactions, xenobiotic toxicity, genetic susceptibility, hepatic metabolism, immune response, corticosteroids, immune checkpoint inhibitors, hepatotoxicity
MeSH terms: Biopsy, Humans, Risk Factors, Biomarkers, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug-induced liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Cited works that were retracted

Citations

Cites

Cited by

Related

Metadata

Record

About these checks